Theator Team (Facebook pic)
Theator, an Israeli medtech startup that offers a surgical intelligence platform, has raised an additional; $24 million as part of its Series A fundraising round led by Insight Partners with support from existing investors including Blumberg Capital, Mayo Clinic and others. This brings the total brought in from the round, which began in February, to $39.5 million.
Israelis have been leaders in the world in developing new medical technologies and treatments for diseases like cancer. And a number of Startup Nation firms have already made headline in the month of July. For example, Israel’s CathWorks, an Israeli medtech firm that offers a non-invasive diagnostic alternative to catheters, has entered into a deal with the international healthcare technology company Medtronic in which Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks’ FFRangio System in the U.S., Europe and Japan.
And Israeli medtech startup ForSight Robotics, which is developing a surgical robotic platform to deliver what it describes as high precision and cost-effective vision-saving surgery, raised $55 million in a Series A round of funding led by The Adani Group alongside existing investors Eclipse Ventures and Mithril Capital.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Founded in 2018 by CEO Tamir Wolf and Dotan Asselmann, Theator is pioneering the Surgical Intelligence revolution. The company boasts that its technology is the next generation of AI in surgery – built by surgeons for surgeons, and designed to raise their expertise to the highest possible level.
Theator says that their goal is not just better surgery, but to create a whole new experience of AI in surgery. A next-generation OR, with real-time surgical decision support and AI-driven robotic procedures – all powered by surgical intelligence.
“Together, we are using real-world scientific data to develop advanced AI capabilities that will fuel more consistently successful surgeries, and ultimately, a healthier world. This is the Surgical intelligence revolution.”
Theator says that its platform allows medical professionals to easily access “defining moments across a range of parameters” including steps, events, milestones and decision-making junctions. It also lets them view each procedure as an ordered list of steps and jump right to the specific step you want to learn from.
“This funding is a strong vote of confidence in our vision, team, and the field of Surgical Intelligence as the cornerstone of the future of surgery,” said Dr. Tamir Wolf, CEO and Co-founder of Theator. “Surgical Intelligence is already demonstrating significant improvement in surgical quality and safety. It’s thrilling to hear about the impact our partners and collaborators have achieved thus far, and we look forward to this latest investment advancing our mission to transform surgery and alleviate variability and disparity in surgical care worldwide.”
